CARSON CITY, Nev., Nov. 13, 2012 /PRNewswire/ -- Millions of laboratory tests and biological assays are conducted every year to explore cellular processes. Quantum Materials Corporation has now developed tetrapod quantum dots, improved fluorescent markers that can more effectively gain knowledge of how body systems function and chronic conditions and diseases such as cancer metabolize and impact health and longevity.
Conventionally, fluorescent tags or tracers have been used to "light up" and distinguish one type of cell from another to gain these insights into biological functions. However, these tags and other dyes have drawbacks to use, including quick fading and tedious procedures to differentiate more than one type of cell or bio-molecule at a time.
The discovery of quantum dots as a fluorescent marker has made these biochemical assays quicker and more robust for scientific discovery. The quantum dots are proving to be more stable and have a unique capability to shine in multiple colors under a single light source excitation so that a single assay can produce much more information for researchers.
Quantum Materials Corporation has now increased the brightness of its tetrapod-shaped quantum dots for this application. At a quantum yield greater than 80%, the dots are bright enough to be functionalized in a wide variety of ways to perform as novel probes into as-of-yet-not-fully-understood biological systems. This functionalization typically will allow researchers to modify the base quantum dot so that a biological tag can be made with an appropriate protein or antibody for a very specific marking within the laboratory sample.
Quantum Materials' CEO Stephen Squires noted that, "We believe that the brightness of our Tetrapod Quantum Dots along with other unique features, will give key players in the pharmaceutical and biological industries a much awaited, high performance tool to dig in deeper to the mysteries of physiological conditions that have eluded efforts for cures."
In combination with Quantum Materials use of high throughput microreactor technology the production of the high quantum yield, bright quantum dots will potentially enable the millions of annual assays to expand significantly in number and provide desperately needed information to be quickly available to the world's leading researchers.
In addition to the performance increases for biomedical applications, Quantum Materials believes that the technology breakthrough will also enable its subsidiary, Solterra Renewable Materials to increase conversion efficiencies for its thin-film quantum dot solar cell. With advances in the solar cell, QMC expects to then apply insight gained in the added performance to other quantum dot applications such as LED lighting and displays.
About Quantum Materials, Inc., Solterra Renewable Technologies, Inc.
QUANTUM MATERIALS CORPORATION has a steadfast vision that advanced technology is the solution to global issues related to cost, efficiency and increasing energy usage. Quantum dot semiconductors enable a new level of performance in a wide array of established consumer and industrial products, including low cost flexible solar cells, low power lighting and displays and biomedical research applications. Quantum Materials Corporation intends to invigorate these markets through cost reduction and moving laboratory discovery to commercialization with volume manufacturing methods to establish a growing line of innovative high performance products. (http://www.quantummaterials.us)
SOLTERRA RENEWABLE TECHNOLOGIES, INC. is singularly positioned to lead the development of truly sustainable and cost-effective solar technology by introducing a new dimension of cost reduction by replacing silicon wafer-based solar cells with high-production, low-cost, efficient Quantum Dot-based solar cells. Solterra is a wholly-owned subsidiary of Quantum Materials, Inc. (http://www.solterrasolarcells.com).
Safe Harbor statement under the Private Securities Litigation Reform Act of 1995
This press release contains forward-looking statements that involve risks and uncertainties concerning our business, products, and financial results. Actual results may differ materially from the results predicted. More information about potential risk factors that could affect our business, products, and financial results are included in our annual report and in reports subsequently filed by us with the Securities and Exchange Commission ("SEC"). All documents are available through the SEC's Electronic Data Gathering Analysis and Retrieval System (EDGAR) at http://www.sec.gov/ or from our website. We hereby disclaim any obligation to publicly update the information provided above, including forward-looking statements, to reflect subsequent events or circumstances.
For more information, please contact:
Art Lamstein (Director of Marketing) at: firstname.lastname@example.org, 415-883-4556
SOURCE Quantum Materials Corporation